These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14090641)

  • 21. Rifamycin Derivatives Are Effective Against Staphylococcal Biofilms In Vitro and Elutable From PMMA.
    Sanchez CJ; Shiels SM; Tennent DJ; Hardy SK; Murray CK; Wenke JC
    Clin Orthop Relat Res; 2015 Sep; 473(9):2874-84. PubMed ID: 25896136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rifamycin SV in the treatment of pyopneumothorax complicating staphylococcal bullous pneumopathy of infants].
    CERIANA G
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():336-7. PubMed ID: 14019688
    [No Abstract]   [Full Text] [Related]  

  • 23. [PATHOGENIC STAPHYLOCOCCI AMONG THE FLORA OF CHRONIC BRONCHITIS PATIENTS AND IN VITRO SENSITIVITY TO RIFOMYCIN AND OTHER ANTIBIOTICS].
    AZNARREIG A; REYCALERO J; SANCHIS-BAYARRI V
    Rev Clin Esp; 1964 Dec; 95():295-302. PubMed ID: 14283214
    [No Abstract]   [Full Text] [Related]  

  • 24. [OBSERVATIONS ON THE USE OF INTRAVENOUS RIFAMYCIN SV].
    SCALABRINO R
    Chemotherapia (Basel); 1963; 27():302-5. PubMed ID: 14128789
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rifamycin SV in the treatment of fistulized pyopneumothorax of children].
    CARRATU L
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():265-8. PubMed ID: 14018868
    [No Abstract]   [Full Text] [Related]  

  • 26. [RIFAMYCIN SV IN THE TREATMENT OF PLEURAL AND PULMONARY DISEASES].
    FREOUR P; GERMOUTY J; DE SOUZA M
    Chemotherapia (Basel); 1963; 27():321-6. PubMed ID: 14128793
    [No Abstract]   [Full Text] [Related]  

  • 27. [CLINICAL EXPERIENCE WITH RIFAMYCIN SV].
    ISHIYAMA S; TAKEDA M
    J Antibiot B; 1963 Jun; 16():207-9. PubMed ID: 14043982
    [No Abstract]   [Full Text] [Related]  

  • 28. [RESEARCH IN VITRO ON THE ANTIBACTERIAL ACTIVITY OF RIFOMYCIN SV IN ASSOCIATION WITH OTHER ANTIBIOTICS].
    NINNI A; VACCARO L
    G Ital Chemioter; 1963; 10():257-60. PubMed ID: 14164381
    [No Abstract]   [Full Text] [Related]  

  • 29. [COMPARATIVE RESISTANCE OF STAPHYLOCOCCUS AUREUS NOT PRODUCING PENICILLINASE TO PENICILLIN IN VIVO AND IN VITRO].
    DRATVIN SA
    Antibiotiki; 1964 Apr; 9():334-8. PubMed ID: 14223631
    [No Abstract]   [Full Text] [Related]  

  • 30. [RIFAMYCIN SV IN THE SUPPURATING AFFECTIONS OF THE LOCOMOTOR APPARATUS].
    BRENNER EA; GIANI O
    Sem Med; 1963 Jun; 122():1468-72. PubMed ID: 14069264
    [No Abstract]   [Full Text] [Related]  

  • 31. [RIFAMYCIN S.V.; CLINICOBACTERIOLOGICAL STUDIES].
    CRISCUOLO E; PARAJE R; BAISTROCCHI JD
    Prensa Med Argent; 1964 Jul; 51():233-43. PubMed ID: 14190192
    [No Abstract]   [Full Text] [Related]  

  • 32. [COMBINED EFFECT OF TETRACYCLINE AND NOVOIMANIN ON STAPHYLOCOCCUS AUREUS IN VITRO].
    AZIMKHODZHAEVA MN
    Mikrobiol Zh; 1964; 26():35-40. PubMed ID: 14263614
    [No Abstract]   [Full Text] [Related]  

  • 33. [A NEW ANTIBIOTIC AGENT: RIFAMYCIN SV].
    GERBER R
    Chemotherapia (Basel); 1963; 27():327-30. PubMed ID: 14128794
    [No Abstract]   [Full Text] [Related]  

  • 34. [SENSITIVITY OF STAPHYLOCOCCI TO RIFAMYCIN SV].
    HAUDUROY P; ROSSET W
    Chemotherapia (Basel); 1963; 5358():315-8. PubMed ID: 14044891
    [No Abstract]   [Full Text] [Related]  

  • 35. [STUDY OF POSSIBLE INTERACTION BETWEEN INFLUENZA VIRUS AND STAPHYLOCOCCUS AUREUS. II. ON THE GROWTH OF STAPHYLOCOCCUS AUREUS AFTER IN VITRO CONTACT WITH A PURIFIED STRAIN OF INFLUENZA VIRUS].
    BUCHI G; THIBON M; CATEIGNE G
    Ann Inst Pasteur (Paris); 1965 Jan; 108():95-9. PubMed ID: 14289984
    [No Abstract]   [Full Text] [Related]  

  • 36. [RIFAMYCIN SV IN PEDIATRIC PRACTICE: NEW ADMINISTRATION ROUTES].
    GIUSTI M; MOGGI P; MORI S
    Chemotherapia (Basel); 1963; 27():295-301. PubMed ID: 14128788
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro and ex vivo influence of rifamycins on human phagocytes.
    Bersani C; Bertoletti R; Colombo ML; Merlini C; Uccelli M; Fietta A; Gialdroni Grassi G
    Chemioterapia; 1987 Dec; 6(6):420-5. PubMed ID: 3435923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CLINICAL TRIALS OF THE NEW ANTIBIOTIC, RIFAMYCIN SV: PRELIMINARY REPORT].
    NEUMAYR A; STOEFLER G
    Chemotherapia (Basel); 1963; 12():437-8. PubMed ID: 14185768
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice.
    Craven N; Anderson JC
    Am J Vet Res; 1983 Apr; 44(4):709-12. PubMed ID: 6553464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antimycobacterial activity of rifamycin SV in vitro].
    NITTI V
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():177-89. PubMed ID: 13938848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.